Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
04/06DJPfizer, Allergan to Hunt for Deals of Their Own
04/06 Oil, healthcare boost stocks; dollar weak after minutes
04/06 Oil, healthcare boost global stocks; dollar weak after minutes
04/06DJPFIZER : Treasury Has Outsize Legal Leverage on Inversions
04/06DJFDA Approves Medtronic Pacemaker That Attaches Directly to Heart
04/06 Mega-deal collapse a second-quarter wake-up for merger-arb hedge funds
04/06DJAllergan CEO Saunders Criticizes Treasury Rules That Scuttled Pfizer Deal
04/06DJPFIZER : Allergan End Merger Agreement -- 2nd Update
04/06 Democratic White House hopefuls cheer end of Pfizer, Allergan deal
04/06 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
04/06 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
04/06DJMedtronic Says New Inversion Rules Won't Hurt Finances
04/06DJPFIZER : Files 8K - Termination Of Definitive Agreement
04/06DJPfizer, Allergan End Merger Agreement -- Update
04/06DJPfizer Walks Away From Allergan Deal
04/06DJPFIZER : Drops Allergan Takeover -- WSJ
04/06DJHealth-Care Companies Lead U.S. Stocks Higher
04/06 Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
04/06DJPFIZER : to Walk Away From Allergan Deal
04/06DJPFIZER : to Walk Away From Allergan Deal
04/05 Dollar touches 17-month low vs yen as stocks slump
04/05 Obama urges Congress to take action on corporate tax reform
04/05 Dollar drops to 17-month low vs. yen as stocks slump
04/05 EXCLUSIVE : Pfizer leaning towards abandoning deal with Allergan - source
04/05 EXCLUSIVE : Pfizer leaning toward abandoning deal with Allergan - source
04/05DJU.S. HOT STOCKS : Hot Stocks to Watch
04/05DJPFIZER : U.S. Sets Tougher Rules On Tax Deals
04/05 New U.S. inversion rules threatens Pfizer-Allergan deal
04/05 New U.S. inversion rules threatens Pfizer-Allergan deal
04/05DJPFIZER : New Rules on Tax Inversions Threaten Pfizer-Allergan Deal -- 3rd Update
04/05 Wall Street pulls back after recent rally
04/04DJPFIZER : New Rules on Tax Inversions Threaten Pfizer-Allergan Deal -- 2nd Update
04/04DJPFIZER : New Rules on Tax Inversions Threaten Pfizer-Allergan Deal -- Update
04/04DJNew Rules on Tax Inversions Threaten Pfizer-Allergan Deal
04/01DJPFIZER : Cholesterol Drug Meets Co-Primary Endpoints in Latest Study
03/31 U.S. FTC sues Endo alleging antitrust violations
03/31DJFTC Accuses Endo of Paying Off Generic Drugmakers
03/30DJFTC Seeks More Information on Pfizer-Allergan Merger
03/30DJPFIZER : FTC Seeks More Information on Pfizer-Allergan Merger
03/29DJSHIRE : Wins US Patent Trial for Bowel Disease Drug
03/21 TIMELINE : Shakeup at Valeant as longtime CEO Pearson leaving
03/18DJPFIZER : Sanders Urges New Tax Rules On Inversion Deals
03/18DJValeant Rout Vindicates Allergan Directors
03/17DJGlaxo CEO Andrew Witty to Retire
03/16DJWILLIAM ACKMAN : Bill Ackman Sheds Assets, as Pershing Portfolio Sinks
03/15DJPfizer CEO's 2015 Total Pay Valued at $18 Million
03/15DJIAN READ : Pfizer CEO Read's 2015 Total Pay Valued at $18 Million
03/15 TIMELINE : More trouble for Valeant as possible debt default looms
03/15DJTEVA PHARMACEUTICAL : Acquisition of Allergan Generics Unit Delayed--Update
03/15DJTeva Acquisition of Allergan Generics Unit Delayed
03/15DJTEVA PHARMACEUTICAL : Acquisition of Allergan Generics Unit Delayed
03/15 Teva Pharm sees close of $40.5 billion Allergan generics deal by June
03/10DJTEVA PHARMACEUTICAL : EU Approves Teva Takeover of Allergan Generics Unit -- Upd..
03/10DJEU Approves Teva Takeover of Allergan Generics Unit
03/10DJTEVA PHARMACEUTICAL : EU Approves Teva's Takeover of Allergan's Generics Unit
03/10 EU approves Teva bid for Allergan's generics with conditions
03/10 EXCLUSIVE - TEVA SET TO WIN EU OKAY : sources
03/09DJTeva Deal for Allergan Generics Unit Expected to Get Europe OK -Reuters
03/08DJValeant in Talks to Add New Board Members
02/29DJValeant CEO Michael Pearson Returns From Medical Leave
02/22 Allergan's revenue beats on higher U.S. brand sales
02/22DJALLERGAN : Tops Expectations on Botox Sales -- Update
02/22DJAllergan Tops Expectations on Botox Sales
02/19 Teva offers EU concessions over Allergan generics deal
02/17 GEORGE SOROS : filing
02/12DJLILLY : U.K. Court Rules in Opponent's Favor on Alimta Patent
02/12DJELI LILLY : Lilly : U.K. Court Rules in Opponent's Favor on Alimta Patent
02/12 Eli Lilly loses latest round in UK drug patent battle
02/11DJTeva Pharmaceuticals Reports Sales Decline
02/11DJTEVA PHARMACEUTICALS : Reports Sales Decline
02/08DJPFIZER : Outlines Post-Merger Management Slate
02/08DJPFIZER : Outlines Post-Allergan Merger Management Slate
02/08 Pfizer unveils management line up for combined company
02/02 Pfizer 2016 forecast disappoints
02/02DJPFIZER : Beats Expectations but Guidance Disappoints
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2016 14 821 M
EBIT 2016 7 602 M
Net income 2016 -
Debt 2016 17 701 M
Yield 2016 -
P/E ratio 2016 8,45
P/E ratio 2017 427,43
EV / Sales 2016 7,59x
EV / Sales 2017 6,75x
Capitalization 94 775 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 299 $
Spread / Average Target 25%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Brenton L. Saunders President, Chief Executive Officer & Director
Paul M. Bisaro Executive Chairman
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC94 506
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
More Results